Lean goes by a lot of names: purple drank, sizzurp, dirty Sprite, Texas tea. Whatever it is called, the substance at the center of it is codeine, a Schedule II opioid. The sweet taste and the styrofoam cup have made lean look casual for decades, but the clinical reality is less forgiving. Codeine creates the same cycle of tolerance, dependence, and withdrawal as other opioids, and the illicit version circulating today carries an additional risk that did not exist ten years ago: fentanyl contamination. This guide explains what lean actually is, why it produces opioid use disorder, and what treatment looks like for someone who needs help.
Lean is a recreational mixture made by combining prescription-strength cough syrup containing codeine and promethazine with a carbonated soft drink, usually Sprite or another clear soda, and sometimes hard candy for sweetness. The codeine in that syrup is an opioid. The promethazine is a sedating antihistamine. Together they depress the central nervous system, producing a slow, euphoric sedation that users describe as a full-body relaxation. That sedation is also why the drink earned its name: people physically lean or slouch after drinking it because their motor control deteriorates.
Lean gained cultural visibility in Houston hip-hop in the early 1990s and spread nationally as the genre did. By the 2000s, references to sizzurp and purple drank appeared routinely in music, sports, and social media. What that visibility obscured was the pharmacology underneath it. Codeine activates the same mu-opioid receptors in the brain as heroin, oxycodone, and fentanyl. Its effects are milder because its potency is lower, not because it works differently.
Codeine binds to opioid receptors and triggers a surge of dopamine in the brain's reward circuitry. With repeated use, the brain recalibrates to expect that dopamine surge and produces less of it on its own. The person needs more codeine to feel the same effect. That is tolerance, and it develops faster than most lean users anticipate, partly because the sweet taste of the drink makes it easy to consume in large quantities without tracking the dose.
Physical dependence follows tolerance. When someone who uses lean regularly stops abruptly, the brain's opioid receptors, accustomed to external codeine, trigger a withdrawal syndrome: anxiety, sweating, muscle aches, insomnia, nausea, and intense cravings. Withdrawal from codeine follows the same pattern as withdrawal from stronger opioids, just typically less severe in intensity. The clinical term for what develops is opioid use disorder.
Research shows that among people who use lean regularly, 91 percent meet diagnostic criteria for a substance use disorder and 74 percent have experienced withdrawal symptoms. According to NIDA's opioid research overview, codeine carries the same addiction profile as prescription opioids. The cultural framing of lean as a mild or soft drug has no clinical basis.
Codeine and promethazine both slow the central nervous system, but through different mechanisms. Codeine suppresses breathing at the opioid receptor. Promethazine adds a second layer of CNS depression through histamine blockade. The combined effect produces respiratory depression more severe than codeine alone would cause. When someone falls asleep after drinking lean, their breathing rate continues to slow without any conscious awareness of it.
Mixing lean with alcohol amplifies that suppression significantly. Alcohol is also a CNS depressant, and combining it with codeine and promethazine creates a compounding effect on the respiratory system that can stop breathing entirely. The same dynamic applies when lean is used alongside benzodiazepines. Most overdose deaths involving lean occur in the context of polysubstance use, which is part of why the drink's casual image is so misleading.
The newer risk is fentanyl contamination in street-sourced lean. Illicitly obtained codeine syrup, or counterfeit syrups sold to look like prescription product, may contain fentanyl. Because fentanyl is 50 to 100 times more potent than morphine, a dose calibrated to feel like lean can produce fatal respiratory arrest with no warning. Someone who believes they are drinking a codeine product they have used before has no way to detect a fentanyl-laced substitute by sight, smell, or taste. Fentanyl test strips can detect contamination before use and are available through many harm reduction organizations.
Because lean looks like a soft drink and is consumed socially, families often do not recognize opioid misuse for what it is. A few patterns are worth knowing.
In teens and young adults, these signs can overlap with other adolescent behavior, which is part of what makes lean use easy to miss. For a broader look at how substance use develops, our piece on why people use drugs covers the psychological and social factors that make certain substances appealing. The key clinical question is not whether someone seems impaired once; it is whether the pattern repeats and whether stopping it causes a physical reaction.
Opioid use disorder is a chronic brain disease with proven, effective treatments. Lean addiction responds to the same evidence-based approaches used for other opioid use disorders because the underlying pharmacology is the same.
Medication-assisted treatment using buprenorphine or methadone reduces cravings, stabilizes brain chemistry, and dramatically lowers the risk of overdose death. The American Society of Addiction Medicine recommends a structured continuum of care, typically beginning with medically supervised withdrawal management, followed by an appropriate level of outpatient or residential treatment.
A combination of medication and behavioral therapy, particularly cognitive behavioral therapy and motivational interviewing, produces the strongest long-term outcomes. One barrier specific to lean use is that many people who develop an opioid use disorder through lean do not self-identify as having an opioid problem. They associate opioid addiction with heroin or pills, not a sweetened drink. Clinical providers working with this population benefit from asking directly about lean use as a routine intake question, without assumption or judgment.
For family members looking for guidance, SAMHSA's National Helpline (1-800-662-4357) connects people with local treatment programs at no cost and is available 24 hours a day.
Yes. Purple drank, sizzurp, dirty Sprite, and Texas tea are all regional or colloquial names for the same substance: a mixture of codeine-promethazine prescription cough syrup combined with a soft drink. The names vary by region and era but describe the same formulation and the same risks.
Yes. Lean overdose is documented and fatal. The combination of codeine and promethazine suppresses breathing through two simultaneous mechanisms. Adding alcohol or a benzodiazepine to lean dramatically raises overdose risk. Street-sourced lean now carries a documented fentanyl contamination risk that makes a single dose potentially lethal regardless of previous tolerance.
Codeine is a mu-opioid receptor agonist with a well-established addiction profile. Occasional use can escalate to regular use as tolerance develops and the brain's reward system begins to associate the drug with relief from stress or discomfort. Research shows a high proportion of regular lean users meet diagnostic criteria for opioid use disorder, and many report they did not realize how dependent they had become until they tried to stop.
Approach the conversation without judgment and lead with concern for their health rather than anger about the substance. If the person is open to help, the SAMHSA National Helpline (1-800-662-4357) is free, confidential, and available 24 hours a day. If you are witnessing signs of overdose, including slow or stopped breathing and unresponsiveness, call 911 immediately and administer naloxone if it is available. Naloxone reverses opioid overdose and is available without a prescription at most pharmacies.
Opioid use disorder, regardless of which opioid started it, responds to treatment. People recover from lean addiction every day with the right medical and behavioral support. The cultural normalization of lean does not change the underlying biology, and recognizing the problem for what it is, an opioid use disorder, is what opens the door to effective care.
If you or someone you care about is struggling with lean or any opioid use, our treatment finder can connect you with accredited programs near you. Help is available now.
